147 related articles for article (PubMed ID: 34696298)
1. Avian Cell Line DuckCelt
Chupin C; Pizzorno A; Traversier A; Brun P; Ogonczyk-Makowska D; Padey B; Milesi C; Dulière V; Laurent E; Julien T; Galloux M; Lina B; Eléouët JF; Moreau K; Hamelin ME; Terrier O; Boivin G; Dubois J; Rosa-Calatrava M
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696298
[TBL] [Abstract][Full Text] [Related]
2. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
[TBL] [Abstract][Full Text] [Related]
3. Experimental studies from shake flasks to 3 L stirred tank bioreactor of nutrients and oxygen supply conditions to improve the growth of the avian cell line DuckCelt®-T17.
Tingaud V; Bordes C; Al Mouazen E; Cogné C; Bolzinger MA; Lawton P
J Biol Eng; 2023 Apr; 17(1):31. PubMed ID: 37095522
[TBL] [Abstract][Full Text] [Related]
4. Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.
Ogonczyk-Makowska D; Brun P; Vacher C; Chupin C; Droillard C; Carbonneau J; Laurent E; Dulière V; Traversier A; Terrier O; Julien T; Galloux M; Paul S; Eléouët JF; Fouret J; Hamelin ME; Pizzorno A; Boivin G; Rosa-Calatrava M; Dubois J
NPJ Vaccines; 2024 Jun; 9(1):111. PubMed ID: 38898106
[TBL] [Abstract][Full Text] [Related]
5. Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development.
Dubois J; Pizzorno A; Cavanagh MH; Padey B; Nicolas de Lamballerie C; Uyar O; Venable MC; Carbonneau J; Traversier A; Julien T; Lavigne S; Couture C; Lina B; Hamelin MÈ; Terrier O; Rosa-Calatrava M; Boivin G
Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31671656
[TBL] [Abstract][Full Text] [Related]
6. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate.
Biacchesi S; Skiadopoulos MH; Yang L; Lamirande EW; Tran KC; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2004 Dec; 78(23):12877-87. PubMed ID: 15542640
[TBL] [Abstract][Full Text] [Related]
8. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
9. Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters.
Schickli JH; Kaur J; Macphail M; Guzzetta JM; Spaete RR; Tang RS
Virol J; 2008 Jun; 5():69. PubMed ID: 18519001
[TBL] [Abstract][Full Text] [Related]
10. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo.
Pham QN; Biacchesi S; Skiadopoulos MH; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2005 Dec; 79(24):15114-22. PubMed ID: 16306583
[TBL] [Abstract][Full Text] [Related]
11. Live vaccines for human metapneumovirus designed by reverse genetics.
Buchholz UJ; Nagashima K; Murphy BR; Collins PL
Expert Rev Vaccines; 2006 Oct; 5(5):695-706. PubMed ID: 17181442
[TBL] [Abstract][Full Text] [Related]
12. Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
Kinder JT; Moncman CL; Barrett C; Jin H; Kallewaard N; Dutch RE
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759319
[TBL] [Abstract][Full Text] [Related]
13. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of Human Metapneumovirus M2-1 Protein Upregulates Viral Replication and Pathogenesis.
Cai H; Zhang Y; Lu M; Liang X; Jennings R; Niewiesk S; Li J
J Virol; 2016 Aug; 90(16):7323-7338. PubMed ID: 27252537
[TBL] [Abstract][Full Text] [Related]
15. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
16. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
Buchholz UJ; Biacchesi S; Pham QN; Tran KC; Yang L; Luongo CL; Skiadopoulos MH; Murphy BR; Collins PL
J Virol; 2005 Jun; 79(11):6588-97. PubMed ID: 15890897
[TBL] [Abstract][Full Text] [Related]
17. Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis.
Wei Y; Zhang Y; Cai H; Mirza AM; Iorio RM; Peeples ME; Niewiesk S; Li J
J Virol; 2014 Apr; 88(8):4338-52. PubMed ID: 24478423
[TBL] [Abstract][Full Text] [Related]
18. Specificity and functional interaction of the polymerase complex proteins of human and avian metapneumoviruses.
de Graaf M; Herfst S; Schrauwen EJA; Choi Y; van den Hoogen BG; Osterhaus ADME; Fouchier RAM
J Gen Virol; 2008 Apr; 89(Pt 4):975-983. PubMed ID: 18343839
[TBL] [Abstract][Full Text] [Related]
19. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates.
Biacchesi S; Pham QN; Skiadopoulos MH; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2005 Oct; 79(19):12608-13. PubMed ID: 16160190
[TBL] [Abstract][Full Text] [Related]
20. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
Hussain AI; Cordeiro M; Sevilla E; Liu J
Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
